| abstract |
The use of a TNF-alpha derived peptide. and comprising a chain of 7 to 17 contiguous amino acids, wherein the peptide has an amino acid sequence comprising a hexamer of TX.sub.1. may be any natural or unnatural amino acid, and exhibit no TNF receptor binding activity, for the preparation of a medicament for the treatment of edema, including pulmonary edema. |